| 摘要 |
The present invention relates to a new use of phosphodiesterase 1 (PDE1) inhibitors for the treatment of psychosis, schizophrenia, schizoaffective disorder, schizophreniform disorder, psychotic disorder, delusional disorder, mania, or bipolar disorder. |
| 申请人 |
INTRA-CELLULAR THERAPIES, INC. |
发明人 |
FIENBERG, ALLEN, A.;WENNOGLE, LAWRENCE, J.;MATES, SHARON |
